Skip Navigation LinksHome > October 2012 - Volume 46 - Issue 9 > Future Prevention and Treatment of Chronic Hepatitis B Infec...
Journal of Clinical Gastroenterology:
doi: 10.1097/MCG.0b013e3182610191
Clinical Reviews

Future Prevention and Treatment of Chronic Hepatitis B Infection

Seto, Wai-Kay MRCP*; Fung, James MD*; Yuen, Man-Fung MD*,†; Lai, Ching-Lung MD*,†

Collapse Box


Vaccination for hepatitis B virus (HBV) infection and treatment for chronic hepatitis B, while effective for primary prevention and control of the disease, still have their limitations. Global coverage of HBV immunization needs improvement. Several patient populations are noted to have suboptimal seroprotective rates after HBV vaccination. There are currently several potential new vaccines undergoing animal and human studies, most notably vaccines containing immunostimulatory DNA sequences. Long-term nucleoside analogue therapy is necessary in achieving permanent virologic suppression. Potential new treatments explore new mechanisms of action, including the inhibition of hepatitis B surface antigen release, targeting antifibrotic mechanism, and immunomodulation through novel interferons and therapeutic vaccines. The clinical application of potential new vaccines and therapies would enhance the prevention of HBV infection and treatment of chronic hepatitis B.

© 2012 Lippincott Williams & Wilkins, Inc.


Article Tools


Article Level Metrics

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.